New retinal imaging techniques have been driven by advances in optics, cameras, computers, and software, and have become extremely helpful guides for the diagnosis and treatment of AMD.
Optical Coherence Tomography
The greatest advance in retinal imaging has come from optical coherence tomography (OCT). This technique uses infrared light reflections off the retina to generate a cross-section retinal view that is displayed on a computer screen.
The images are acquired within a few seconds and do not require any uncomfortable bright light flashes. They show pockets of fluid in the retina in patients with wet AMD, helping to guide the frequency of anti-VEGF injections (Beovu®. Eylea®, Lucentis® or Avastin®). They also show drusen, which are small deposits under the retina in patients with early dry AMD, as well as retinal thinning from cell death in patients with late dry AMD (also called geographic atrophy). Learn more about a leading scientist funded by the BrightFocus National Glaucoma Research program, who helped develop OCT.
A recent improvement to OCT technology is OCT angiography. With this technique, normal and abnormal retinal blood vessels can be seen. This helps the ophthalmologist understand the nature and extent of abnormal blood vessels in people with AMD.
Until OCT angiography was invented, detailed views of retinal blood vessels could only be obtained following intravenous injection of dyes, called fluorescein or indocyanine green (ICG). These tests are more uncomfortable, as they require the injections and sometimes light flashes over a period of 15-30 minutes. However, the tests are still required at times to obtain an accurate and complete picture of the disease process.
Retinal Fundus Photography
Retinal “fundus” photography provides a color picture of the retina. This technique has existed for decades, but has been improved by digital cameras, computers, software, and new optical techniques. It takes only about a minute and requires a few bright flashes. The images obtained can show drusen, blood, or lipids (a group of naturally occurring molecules that include fats) that have leaked out of abnormal blood vessels in wet AMD, scar tissue, and areas where retinal cells have wasted away and died, called atrophy.
Atrophy can also be detected using autofluorescence imaging. This technique, which is also quick and requires just a few flashes of light, yields a view of the retinal pigment epithelial cells (RPE), which die in people who have geographic atrophy. RPE cells protect and nourish the retina, remove waste products, and provide a number of other functions.
Live RPE cells appear bright because they contain the autofluorescent material called lipofuscin, but areas in which the RPE cells have died appear as a dark patch in the photograph, since these areas no longer have lipofuscin.
Scanning Laser Ophthalmoscopy
An even sharper image of the autofluorescent RPE cells can be obtained with a scanning laser ophthalmoscope (SLO), but this imaging takes a bit more time and additional equipment. Even better resolution can be obtained with adaptive optics-SLO (AO-SLO), which borrows technology from high resolution telescopes. This literally uses a space-age technology that provides views of individual cells in the retina, allowing them to be counted. AO-SLO is current available only in research settings.
A relatively new optical advance within a camera made by Optos provides a view of the peripheral retina, rather than just the central retina (macula), and can be helpful in patients with suspected retinal detachment or other peripheral retinal abnormalities.
Talk with your doctor about what, if any, imaging techniques may be right for you.
- Macular Degeneration Toolkit (Helpful Information to Understand and Manage Macular Degeneration)
- Expert Information on Macular Degeneration (Articles)
- BrightFocus Chats (Audio Presentations on Macular Degeneration)
- Macular Degeneration: The Essential Facts (Publication)
- What is Geographic Atrophy? (Article)
This content was last updated on: December 3, 2019
The information provided here is a public service of the BrightFocus Foundation and should not in any way substitute for personalized advice of a qualified healthcare professional; it is not intended to constitute medical advice. Please consult your physician for personalized medical advice. BrightFocus Foundation does not endorse any medical product, therapy, or resources mentioned or listed in this article. All medications and supplements should only be taken under medical supervision. Also, although we make every effort to keep the medical information on our website updated, we cannot guarantee that the posted information reflects the most up-to-date research.
These articles do not imply an endorsement of BrightFocus by the author or their institution, nor do they imply an endorsement of the institution or author by BrightFocus.
Some of the content may be adapted from other sources, which will be clearly identified within the article.